The headline numbers for Comerica (CMA) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Comerica Incorporated (CMA) came out with quarterly earnings of $1.42 per share, beating the Zacks Consensus Estimate of $1.23 per share. This compares to earnings of $1.53 per share a year ago.
CMA's Q2 earnings may fall 19.6% despite revenue gains, as rising expenses and deposit declines weigh on results.
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Comerica (CMA), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2025.
I assign Comerica a hold rating, reflecting a balance between solid fundamentals and short-term risks constraining its outlook. Comerica's disciplined cost management supports stable margins and profitability, even as revenues face pressure from a challenging macro environment. Valuation appears fair, with no clear over or undervaluation, and my conservative DCF suggests limited upside under very conservative assumptions.
Comerica (CMA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The offer by seven of the UK's largest housebuilders to pay £100 million and agree to legally binding restrictions on sharing information with purported rivals to resolve a competition investigation was a "get out of jail free card", one analyst said. Coming on the same day that Sir Brian Leveson published a report with various recommendations to help clear Britain's legal backlog, including calling for more out-of-court settlements, the housebuilders made a similar offer to the Competition and Markets Authority to avoid taking an ongoing investigation further.
The Competition and Markets Authority has started an investigation into Primary Health Properties PLC (LSE:PHP, OTC:PHPRF)' £1.79 billion bid to acquire Assura Group (LSE:AGR). In a statement, the CMA said it will look at whether the deal creates a relevant merger situation and if it could hurt competition in the UK healthcare property markets.
The UK's Competition and Markets Authority (CMA) is proposing tighter regulation of Google, which could force the tech giant to offer users greater choice in search services. Under plans to grant Google “strategic market status”, a designation that allows for stricter oversight of dominant firms, the CMA is considering measures such as “choice screens”.
CMA lowers its 2Q25 deposit outlook amid declines in key segments but expects loan balances to beat prior forecasts.
CMA shares are up 21.2% in a year, fueled by cost cuts, strong NII, and capital returns worth watching despite valuation concerns.
Comerica Incorporated (NYSE:CMA ) Q1 2025 Earnings Conference Call April 21, 2025 8:00 AM ET Company Participants Kelly Gage - Director, IR Curt Farmer - President, Chairman & CEO Jim Herzog - CFO Peter Sefzik - Chief Banking Officer Melinda Chausse - Senior EVP, Chief Credit Officer Conference Call Participants Jon Arfstrom - RBC Capital Markets Scott Siefers - Piper Sandler Ken Usdin - Autonomous Research Manan Gosalia - Morgan Stanley Bernard Von Gizycki - Deutsche Bank John Pancari - Evercore ISI Chris McGratty - KBW Anthony Elian - JPMorgan Chase Brian Foran - Truist Ben Gerlinger - Citi Terry McEvoy - Stephens Nick Holowko - UBS Bill Carcache - Wolfe Research Operator Greetings, and welcome to Comerica First Quarter 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode.